Showing posts with label invasive ovarian cancers. Show all posts
Showing posts with label invasive ovarian cancers. Show all posts
Saturday, February 06, 2010
Chemotherapy Resistance as a Predictor of Progression-Free Survival in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy and Surgical Cytoreduction Followed by Intraperitoneal Chemotherapy: A Southwest Oncology Group Study
re: tumour assay testing
"Conclusions: While the small patient numbers in this trial do not permit definitive conclusions, these data fail to provide support for the argument that prospectively obtained in vitro data regarding platinum or paclitaxel resistance will be highly predictive of clinical outcome in advanced ovarian cancer."
add your opinions
assay testing
,
invasive ovarian cancers
,
platinum resistance
Oncogene - Abstract (technical): Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer
Definition: Cadherins - (Calcium dependant adhesion molecules) are a class of type-1 transmembrane proteins. They play important roles in cell adhesion.
Definition: Gonadotropin - hormone secreted by the anterior pituitary gland and placenta; stimulates the gonads and controls reproductive activity. A hormone that stimulates the ovaries (such as to produce estrogen).
"These results identify for the first time cadherin switching and p120ctn signaling as important targets of GnRH function and as novel mediators of invasiveness and tumor progression in ovarian cancer."
add your opinions
cadherins
,
gonadotropin
,
invasive
,
invasive ovarian cancers
,
research
,
tumor progression
HTML Full Text - Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours
(included ovarian cancer patients in study)
add your opinions
cancer genetics risks
,
first cycle chemotherapy
,
invasive ovarian cancers
,
neutropenia
,
solid tumors
Thursday, February 04, 2010
In Research: Yale Makes Possible Breakthrough in Ovarian Cancer Treatment | NBC Connecticut
"Genetic researchers prevent genes from performing their function, "knocking down" the gene, by inserting small interfering RNA (siRNA) molecules into the cells. The next steps in the team's research will be to examine the effect of siRNA in ovarian cancer samples in the lab, and to test the technique on mice."
add your opinions
genes
,
invasive ovarian cancers
,
RNA
Wednesday, February 03, 2010
Chemotherapy Resistance as a Predictor of Progression-Free Survival in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy and Surgical Cytoreduction Followed by Intraperitoneal Chemotherapy: A Southwest Oncology Group Study
add your opinions
chemotherapy resistance
,
invasive ovarian cancers
,
Oncotech
,
survival
Tuesday, February 02, 2010
Fertility-sparing surgery in young women with invasive epithelial ovarian cancer.
Note: this study also discusses tumour rupture/survival; the abstract does not include specific cell types, however, clear cell can be possibly presumed given the research data on Japanese women with clear cell ovarian cancer.
Subscribe to:
Posts
(
Atom
)